A prospective, single centre, open label, single arm pilot study to evaluate the efficacy and safety of Amlapitta Mishran Suspension in participants with endoscopic gastritis

Background: Endoscopic gastritis is associated with symptoms of gastritis, along with endoscopic findings. Amlapitta Mishran has multiple active components that act via various mechanisms in patients with gastritis symptoms. We planned to conduct this study to find out the efficacy and safety of Aml...

Full description

Bibliographic Details
Main Authors: Yashashri C. Shetty, Paresh G. Koli, Manoj Lahoti, Savita Kulkarni, Preeti Rajput, Mukesh B. Chawda
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Journal of Ayurveda and Integrative Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0975947622001231